litlas
Log inCreate account

Gregory H. Reaman

Active 1979–2025

Also published as
Gregory H Reaman
126
Papers
22,815
Citations
88
h-index
124
i10-index

Citations

Citations per year for Gregory H. Reaman1980: 3 citations1981: 5 citations1982: 3 citations1983: 3 citations1984: 3 citations1985: 2 citations1986: 8 citations1987: 2 citations1988: 7 citations1989: 5 citations1990: 11 citations1991: 11 citations1992: 15 citations1993: 22 citations1994: 23 citations1995: 32 citations1996: 35 citations1997: 55 citations1998: 72 citations1999: 96 citations2000: 116 citations2001: 80 citations2002: 103 citations2003: 105 citations2004: 100 citations2005: 76 citations2006: 98 citations2007: 100 citations2008: 108 citations2009: 160 citations2010: 157 citations2011: 163 citations2012: 282 citations2013: 234 citations2014: 214 citations2015: 266 citations2016: 198 citations2017: 159 citations2018: 140 citations2019: 517 citations2020: 530 citations2021: 502 citations2022: 340 citations2023: 245 citations2024: 396 citations2025: 144 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,638 citing papers, 33% of this breakdownUnited Kingdom: 522 citing papers, 6.5% of this breakdownGermany: 469 citing papers, 5.9% of this breakdownItaly: 400 citing papers, 5% of this breakdownCanada: 376 citing papers, 4.7% of this breakdownFrance: 354 citing papers, 4.4% of this breakdownChina: 344 citing papers, 4.3% of this breakdownNetherlands: 310 citing papers, 3.9% of this breakdownAustralia: 233 citing papers, 2.9% of this breakdownSwitzerland: 189 citing papers, 2.4% of this breakdownSpain: 170 citing papers, 2.1% of this breakdownJapan: 156 citing papers, 1.9% of this breakdown
0%33%Other 23%

Institutions

Fields

  • Medicine76.8%
  • Biochemistry, Genetics and Molecular Biology16.2%
  • Immunology and Microbiology3%
  • Neuroscience0.9%
  • Materials Science0.4%
  • Mathematics0.4%
  • Other2.3%

Topics

  • Acute Lymphoblastic Leukemia research12.2%
  • Childhood Cancer Survivors' Quality of Life7.6%
  • Acute Myeloid Leukemia Research4.6%
  • Neuroblastoma Research and Treatments3.5%
  • Glioma Diagnosis and Treatment3.4%
  • Chronic Myeloid Leukemia Treatments3.3%
  • Other65.4%

Coauthors

All papers

Open in search
  1. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia

    Authors: Charles G. Mullighan, Xiaoping Su, Jinghui Zhang, Ina Radtke, Letha A. Phillips, Christopher B. Miller, Jing Ma, Wei Liu, Cheng Cheng, Brenda A. Schulman, Richard C. Harvey, I‐Ming Chen, Robert Clifford, William L. Carroll, Gregory H. Reaman, W. Paul Bowman, Meenakshi Devidas, Daniela S. Gerhard, Wenjian Yang, Mary V. Relling, Sheila Shurtleff, Dario Campana, Michael J. Borowitz, Ching‐Hon Pui, Malcolm A. Smith, Stephen P. Hunger, Cheryl L. Willman, James R. Downing - New England Journal of Medicine 2009 cited by 1,444

  2. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia

    Authors: Donald A. Berry, Shouhao Zhou, Howard R. Higley, Lata Mukundan, Shuangshuang Fu, Gregory H. Reaman, Brent L. Wood, Gary J. Kelloff, J. Milburn Jessup, Jerald P. Radich - JAMA Oncology 2017 cited by 568

  3. Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

    Authors: Stephen P. Hunger, Xiaomin Lu, Meenakshi Devidas, Bruce M. Camitta, Paul S. Gaynon, Naomi Winick, Gregory H. Reaman, William L. Carroll - Journal of Clinical Oncology 2012 cited by 1,191

  4. Declining childhood and adolescent cancer mortality

    Authors: Malcolm A. Smith, Sean F. Altekruse, Peter C. Adamson, Gregory H. Reaman, Nita L. Seibel - Cancer 2014 cited by 553

  5. FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

    Authors: Denise Casey, Suzanne Demko, A. K. Sinha, Pallavi S. Mishra‐Kalyani, Yuan Li Shen, Sachia G. Khasar, M. Anwar Goheer, Whitney S. Helms, Lili Pan, Yuan Xu, Jianghong Fan, Ruby Leong, Jiang Liu, Yuching Yang, Katherine Windsor, Mei Ou, Olen Stephens, Byeongtaek Oh, Gregory H. Reaman, Abhilasha Nair, Stacy S. Shord, Vishal Bhatnagar, Selena Daniels, Sharon Sickafuse, Kirsten B. Goldberg, Marc R. Theoret, Richard Pazdur, Harpreet Singh - Clinical Cancer Research 2021 cited by 107

  6. Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

    Authors: Malcolm A. Smith, Nita L. Seibel, Sean F. Altekruse, Lynn A. G. Ries, Danielle Melbert, Maura O’Leary, Franklin O. Smith, Gregory H. Reaman - Journal of Clinical Oncology 2010 cited by 1,026

  7. Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

    Authors: Kathryn G. Roberts, Ryan D. Morin, Jinghui Zhang, Martin Hirst, Yongjun Zhao, Xiaoping Su, Shann-Ching Chen, Debbie Payne-Turner, Michelle L. Churchman, Richard C. Harvey, Xiang Chen, Corynn Kasap, Chunhua Yan, Jared Becksfort, Richard P. Finney, David T. Teachey, Shannon L. Maude, Kane Tse, Richard A. Moore, Steven J.M. Jones, Karen Mungall, İnanç Birol, Michael N. Edmonson, Ying Hu, Kenneth Buetow, I‐Ming Chen, William L. Carroll, Lei Wei, Jing Ma, Maria Kleppe, Ross L. Levine, Guillermo Garcia‐Manero, Eric Larsen, Neil P. Shah, Meenakshi Devidas, Gregory H. Reaman, Malcolm A. Smith, Steven W. Paugh, William E. Evans, Stephan A. Grupp, Sima Jeha, Ching‐Hon Pui, Daniela S. Gerhard, J R Downing, Cheryl L. Willman, Mignon L. Loh, Stephen P. Hunger, Marco A. Marra, Charles G. Mullighan - Cancer Cell 2012 cited by 718

  8. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

    Authors: Richard C. Harvey, Charles G. Mullighan, I‐Ming Chen, Walker Wharton, Fady M. Mikhail, Andrew J. Carroll, Huining Kang, Wei Liu, Kevin K. Dobbin, Malcolm A. Smith, William L. Carroll, Meenakshi Devidas, W. Paul Bowman, Bruce M. Camitta, Gregory H. Reaman, Stephen P. Hunger, James R. Downing, Cheryl L. Willman - Blood 2010 cited by 574

  9. JAK mutations in high-risk childhood acute lymphoblastic leukemia

    Authors: Charles G. Mullighan, Jinghui Zhang, Richard C. Harvey, J. Racquel Collins-Underwood, Brenda A. Schulman, Letha A. Phillips, Sarah K. Tasian, Mignon L. Loh, Xiaoping Su, Wei Liu, Meenakshi Devidas, Susan R. Atlas, I‐Ming Chen, Robert Clifford, Daniela S. Gerhard, William L. Carroll, Gregory H. Reaman, Malcolm A. Smith, James R. Downing, Stephen P. Hunger, Cheryl L. Willman - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 560

  10. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

    Authors: Richard C. Harvey, Charles G. Mullighan, Xuefei Wang, Kevin K. Dobbin, George S. Davidson, Edward J. Bedrick, I‐Ming Chen, Susan R. Atlas, Huining Kang, Kerem AR, Carla S. Wilson, Walker Wharton, Maurice Murphy, Meenakshi Devidas, Andrew J. Carroll, Michael J. Borowitz, W. Paul Bowman, James R. Downing, Mary V. Relling, Jun J. Yang, Deepa Bhojwani, William L. Carroll, Bruce M. Camitta, Gregory H. Reaman, Malcolm A. Smith, Stephen P. Hunger, Cheryl L. Willman - Blood 2010 cited by 405

  11. The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer

    Authors: Joseph Flores‐Toro, Subhashini Jagu, Gregory T. Armstrong, David F. Arons, Gregory J. Aune, Stephen J. Chanock, Douglas S. Hawkins, Allison P. Heath, Lee J. Helman, Katherine A. Janeway, Jason Levine, Ellyn Miller, Lynne Penberthy, Charles W.M. Roberts, Eve Shalley, Jack F. Shern, Malcolm A. Smith, Louis M. Staudt, Samuel L. Volchenboum, Jinghui Zhang, Jean C. Zenklusen, Douglas R. Lowy, Norman E. Sharpless, Jaime M. Guidry Auvil, Anthony R. Kerlavage, Brigitte C. Widemann, Gregory H. Reaman, Warren A. Kibbe, James H. Doroshow, on behalf of Childhood Cancer Data Initiative Working Groups, Richard Aplenc, Caitlyn W. Barrett, Naomi Bartley, Vicki Buenger, Ethan Cerami, Susan L. Cohn, Susan I. Colace, Carrye Cost, Brian D. Crompton, Tanja M. Davidsen, Sharon J. Diskin, Jamie Ennis Bloyd, Suzanne J. Forrest, Maryam Fouladi, Amar Gajjar, Julia Glade Bender, Nancy Goodman, M. Monica Gramatges, Casey S. Greene, Julie Guillot, Amanda Haddock, Melissa Haendel, D. Ashley Hill, Amie E. Hwang, Daphne Kaas-Hogan, E. Anders Kolb, Andrew L. Kung, Salvatore La Rosa, Theodore W. Laetsch, Elizabeth R. Lawlor, Philip J. Lupo, Troy A. McEachron, Clay McLeod, Shannon K. McWeeney, Jill P. Mesirov, Sarah Milberg, Andy Olshan, Corrie Painter, Donald W. Parsons, Aubrey Reichard-Eline, Karlyne M. Reilly, Adam Resnick, Abby B. Sandler, Nita L. Seibel, Nilay D. Shah, David A. Siegel, Logan G. Spector, E. Alejandro Sweet‐Cordero, Gail E. Tomlinson, Emily S. Tonorezos, James V. Tricoli, Olena M. Vaske, Mary Frances Wedekind, Brent R. Weil, Torunn I. Yock - Journal of Clinical Oncology 2023 cited by 47

  12. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas

    Authors: R. J. Packer, Joann L. Ater, Jeffrey C. Allen, Peter C. Phillips∥, Russ Geyer, H. Stacy Nicholson, Regina Jakacki, Elizabeth Kurczynski, Michael N. Needle, Jonathan L. Finlay, Gregory H. Reaman, James M. Boyett - Journal of neurosurgery 1997 cited by 639

  13. Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group

    Authors: Maura O’Leary, Mark Krailo, James R. Anderson, Gregory H. Reaman - Seminars in Oncology 2008 cited by 288

  14. A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

    Authors: Vassilios I. Avramis, Susan Sencer, Antonia Periclou, Harland N. Sather, Bruce Bostrom, Lewis Cohen, Alice G. Ettinger, Lawrence J. Ettinger, Janet Franklin, Paul S. Gaynon, Joanne M. Hilden, Beverly J. Lange, Fataneh Majlessipour, Pracad Mathew, Michael N. Needle, Joseph P. Neglia, Gregory H. Reaman, John S. Holcenberg - Blood 2002 cited by 494

  15. American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care

    Authors: Mary S. McCabe, Ravi Bhatia, Kevin C. Oeffinger, Gregory H. Reaman, Courtney Tyne, Dana S. Wollins, Melissa M. Hudson - Journal of Clinical Oncology 2013 cited by 473

  16. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

    Authors: Andrew D.J. Pearson, Elly Barry, Yaël P. Mossé, Franca Ligas, Nick Bird, Teresa de Rojas, Zachary Zimmerman, Keith D. Wilner, Willi Woessmann, Susan Weiner, Brenda J. Weigel, Rajkumar Venkatramani, D Valteau, Toby N. Trahair, Malcolm A. Smith, Sonia Singh, Giovanni Selvaggi, Nicole Scobie, Gudrun Schleiermacher, Nicholas C. Richardson, Julie Park, Karsten Nysom, Koen Norga, Margret Merino, Joe McDonough, Yousif Matloub, Lynley V. Marshall, Eric Lowe, Giovanni Lesa, Meredith S. Irwin, Dominik Karres, Amar Gajjar, François Doz, Elizabeth Fox, Steven G. DuBois, Martha Donoghue, Michela Casanova, Hubert Caron, Victoria Buenger, Diana Bradford, P. Blanc, Amy Barone, Gregory H. Reaman, Gilles Vassal - European Journal of Cancer 2021 cited by 49

  17. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study

    Authors: I‐Ming Chen, Richard C. Harvey, Charles G. Mullighan, Julie M. Gastier‐Foster, Walker Wharton, Huining Kang, Michael J. Borowitz, Bruce M. Camitta, Andrew J. Carroll, Meenakshi Devidas, DJ Pullen, Debbie Payne-Turner, Sarah K. Tasian, Shalini C. Reshmi, Catherine E. Cottrell, Gregory H. Reaman, W. Paul Bowman, William L. Carroll, Mignon L. Loh, Naomi Winick, Stephen P. Hunger, Cheryl L. Willman - Blood 2012 cited by 247

  18. ACCELERATE – Five years accelerating cancer drug development for children and adolescents

    Authors: Andrew D.J. Pearson, Susan Weiner, Peter C. Adamson, Dominik Karres, Gregory H. Reaman, Raphaël F. Rousseau, P. Blanc, Koen Norga, Jeffrey Skolnik, Pamela Kearns, Nicole Scobie, Elly Barry, Lynley V. Marshall, Leona Knox, Hubert Caron, Darshan Wariabharaj, Alberto S. Pappo, Steven G. DuBois, Lia Gore, Mark W. Kieran, Brenda J. Weigel, Elizabeth Fox, Karsten Nysom, Teresa de Rojas, Gilles Vassal - European Journal of Cancer 2022 cited by 48

  19. FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma

    Authors: Margret Merino, Yvette L. Kasamon, Hongshan Li, Lian Ma, Ruby Leong, Jiaxi Zhou, Gregory H. Reaman, Wiley Chambers, Nicholas C. Richardson, Marc R. Theoret, Richard Pazdur, Nicole Gormley - Pediatric Blood & Cancer 2022 cited by 34

  20. Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer

    Authors: Lorena Lazo de la Vega, Hannah Comeau, S. E. Sallan, Alyaa Al‐Ibraheemi, Hersh Gupta, Yvonne Y. Li, Harrison Tsai, Wenjun Kang, Abigail Ward, Alanna J. Church, AeRang Kim, Navin Pinto, Margaret E. Macy, Luke Maese, Amit J. Sabnis, Andrew D. Cherniack, Neal I. Lindeman, Megan E. Anderson, Tabitha Cooney, Kee Kiat Yeo, Gregory H. Reaman, Steven G. DuBois, Natalie B. Collins, Bruce E. Johnson, Katherine A. Janeway, Suzanne J. Forrest - JCO Precision Oncology 2022 cited by 19

  21. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

    Authors: Andrew D.J. Pearson, Sara M. Federico, Susanne A. Gatz, Michael V. Ortiz, Giovanni Lesa, Nicole Scobie, Ioannis Gounaris, Susan Weiner, Brenda J. Weigel, TJ Unger, Elizabeth Stewart, Malcolm A. Smith, Emily K. Slotkin, Gregory H. Reaman, Alberto S. Pappo, Karsten Nysom, Koen Norga, Joe McDonough, Lynley V. Marshall, Donna Ludwinski, Franca Ligas, Dominik Karres, Marcel Kool, Thierry Horner, Anton G. Henssen, Delphine Heenen, Douglas S. Hawkins, Lia Gore, Julia Glade Bender, Sara Galluzzo, Elizabeth Fox, Teresa de Rojas, Barry R. Davies, Jayeta Chakrabarti, Juliet Carmichael, Diana Bradford, P. Blanc, Ronald J. Bernardi, Sylvie Benchetrit, Korede Akindele, Gilles Vassal - European Journal of Cancer 2023 cited by 16

  22. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.

    Authors: Anne Angiolillo, Cecilia Sgadari, D D Taub, Fang Liao, Joshua Μ. Farber, S. Maheshwari, Hynda K. Kleinman, Gregory H. Reaman, Giovanna Tosato - The Journal of Experimental Medicine 1995 cited by 713

  23. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.

    Authors: Roger J. Packer, Beverly J. Lange, J Ater, H. Stacy Nicholson, Jeffrey C. Allen, Russell Walker, Michael D. Prados, Regina I. Jakacki, Gregory H. Reaman, Mark Needles - Journal of Clinical Oncology 1993 cited by 357

  24. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA

    Authors: Philipp Kapranov, Georges St. Laurent, Tal Raz, Fatih Ozsolak, C. Patrick Reynolds, Poul H. Sorensen, Gregory H. Reaman, Patrice M. Milos, R.J. Arceci, John F. Thompson, Timothy J. Triche - BMC Biology 2010 cited by 296